Your browser doesn't support javascript.
Enhancement of SARS-CoV-2 vaccine-induced immunity by a Toll-like receptor 7 agonist adjuvant.
Li, Gen; Yu, Meixing; Ke, Qiong; Sun, Jing; Peng, Yanwen; Xiong, Chuanfeng; Monteiro, Olivia; Zhao, Jincun; Xiang, Andy P.
  • Li G; Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. superleegen@hotmail.com.
  • Yu M; Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Ke Q; Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University, Guangzhou, China.
  • Sun J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Peng Y; Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University, Guangzhou, China.
  • Xiong C; Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University, Guangzhou, China.
  • Monteiro O; Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology, Macau, China.
  • Zhao J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China. zhaojincun@gird.cn.
  • Xiang AP; Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University, Guangzhou, China. xiangp@mail.sysu.edu.cn.
Signal Transduct Target Ther ; 8(1): 213, 2023 05 24.
Artículo en Inglés | MEDLINE | ID: covidwho-20238614

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Receptor Toll-Like 7 / Vacunas contra la COVID-19 / COVID-19 Tópicos: Vacunas Límite: Humanos Idioma: Inglés Revista: Signal Transduct Target Ther Año: 2023 Tipo del documento: Artículo País de afiliación: S41392-023-01485-6

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Receptor Toll-Like 7 / Vacunas contra la COVID-19 / COVID-19 Tópicos: Vacunas Límite: Humanos Idioma: Inglés Revista: Signal Transduct Target Ther Año: 2023 Tipo del documento: Artículo País de afiliación: S41392-023-01485-6